Targeting post-translational modifications of histones for cancer therapy.

Hsu, Y-C; Hsieh, Y-H; Liao, C-C; Chong, L-W; Lee, C-Y; Yu, Y-L; Chou, R-H.

Afiliação

Hsu YC; Mackay Medical College Institute of Biomedical Sciences New Taipei City Taiwan.
Hsieh YH; Chung Shan Medical University Department of Biochemistry, School of Medicine Taichung Taiwan.
Liao CC; National Yang—Ming University Proteomics Research Center Taipei Taiwan.
Chong LW; Shin Kong Wu Ho—Su Memorial Hospital Division of Hepatology and Gastroenterology, Department of Internal Medicine Taipei Taiwan.
Lee CY; I—Shou University School of Chinese Medicine for Post—Baccalaureate Kaohsiung Taiwan.
Yu YL; China Medical University Graduate Institute of Cancer Biology and Center for Molecular Medicine Taichung Taiwan ylyu&commat;mail.cmu.edu.tw.
Chou RH; China Medical University Graduate Institute of Cancer Biology and Center for Molecular Medicine Taichung Taiwan rhchou&commat;mail.cmu.edu.tw.

Cell Mol Biol (Noisy-le-grand) ; 61(6): 69-84, 2015 Oct 30.

Article em En | MEDLINE | ID: mdl-26518898

Assuntos

Histonas/metabolismo; Neoplasias/tratamento farmacológico; Neoplasias/genética; Acetilação; Animais; Apoptose; Proliferação de Células; Histona Desacetilases/metabolismo; Histonas/química; Humanos; Neoplasias/metabolismo; Processamento de Proteína Pós-Traducional/efeitos dos fármacos

Buscar no Google